Across BMI strata, miscarriage rates were comparable between semaglutide users and controls, with no statistically significant differences detected
Additionally, finerenone demonstrated significant cardiovascular benefits in adults with type 2 diabetes and CKD, evaluated in the FIGARO-DKD trial [70]
Regular Monitoring: Every 3 to 6 Months Once youre on a stable dose, youll need tests every 3 to 6 months
CGM provides a real-time assessment of glucose fluctuations
Patil HR, Al Badarin FJ, Al Shami HA, Bhatti SK, Lavie CJ, Bell DS, OKeefe JH: Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus
Kirkegaard T et al (2010) Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology